Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02293109
Recruitment Status : Recruiting
First Posted : November 18, 2014
Last Update Posted : March 2, 2018
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018